Assessment of Color Vision in Diabetic Patients

Retinopathy, Diabetic Clinical Trial

Official title:

Assessment of Color Vision in Diabetic Patients Before and After the Use of Anti-vegf in the Treatment of Diabetic Macular Edema

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03345667
• Other study ID #: TRABALHO PEDRO ARVO 2018
• Status: Completed
• Phase: N/A
• First received: November 7, 2017
• Last updated: November 16, 2017
• Start date: August 1, 2017
• Est. completion date: October 30, 2017

Study information

• Verified date: November 2017
• Source: Instituto de Olhos de Goiania
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Assessment of color vision in diabetic patients before and after the use of anti-vegf in the treatment of diabetic macular edema

Recruitment information / eligibility

• Status: Completed
• Enrollment: 30
• Est. completion date: October 30, 2017
• Est. primary completion date: October 1, 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 1 Year to 100 Years

Eligibility

Inclusion Criteria:

• Having diabetic retinopathy with macular edema

Exclusion Criteria:

• Not having diabetic retinopathy with macular edema

Related Conditions & MeSH terms

• Diabetic Retinopathy
• Retinopathy, Diabetic

Intervention

Drug:
• lucentis
Use of lucentis and other anti-vegf in patients with diabetic retinopathy

Locations

Country	Name	City	State
Brazil	Instituto de Olhos de Goiania	Goiânia	Goias

Sponsors (1)

Lead Sponsor	Collaborator
Instituto de Olhos de Goiania

Country where clinical trial is conducted

Brazil, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assessment of color vision in diabetic patients before and after the use of anti-vegf in the treatment of diabetic macular edema	Using the Ishihara's test to analise the possible loss of vision	3 months
Secondary	Frame between the injections	Ant-Vegf	1 months